Soleno Therapeutics, Inc. (SLNO) Tops Q4 EPS by 19c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St set for higher open as Anthropic's IPO filing sharpens AI focus
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts SLNO Hot Sheet
Join SI Premium – FREE
Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q4 EPS of $0.80, $0.19 better than the analyst estimate of $0.61. Revenue for the quarter came in at $91.73 million versus the consensus estimate of $82.45 million.
For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iran Ready To Back 'Any Understanding' For Regional Unity - IRIB
- Booz Allen Hamilton rises on TD Cowen upgrade to buy
- United Therapeutics Corp. (UTHR) PT Raised to $850 at Cantor Fitzgerald
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
